Use of KOR agonist in combination with MOR agonist in preparing drug for treating pain
US11471503B2 · kind B2 · utility
0Cited by
0References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 5, 2018 |
| Grant date | Oct 18, 2022 |
| Priority date | — |
| Expiry date | Mar 30, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed is the use of a KOR agonist in combination with a MOR agonist in preparing a drug for treating pain. The KOR agonist is selected from a compound as shown in the general formula (I), and the MOR agonist is selected from a compound as shown in the general formula (II), wherein the definitions of each substituent in the general formula (I) and (II) are the same as defined in the description.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.